Europe Drug-Eluting Stents Market Report 2016

November 2016 | 100 pages | ID: EB410CB9289EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Drug-Eluting Stents

Revenue, means the sales value of Drug-Eluting Stents

This report studies sales (consumption) of Drug-Eluting Stents in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Abbott Vascular (USA)
• Boston Scientific, Inc. (USA)
• Biosensors International Pte Ltd. (Singapore)
• Medtronic, Inc.(USA)
• MIV Therapeutics, Inc. (Canada)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Drug-Eluting Stents in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Drug-Eluting Stents in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Drug-Eluting Stents Market Report 2016

1 DRUG-ELUTING STENTS OVERVIEW

1.1 Product Overview and Scope of Drug-Eluting Stents
1.2 Classification of Drug-Eluting Stents
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Drug-Eluting Stents
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Drug-Eluting Stents Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Drug-Eluting Stents (2011-2021)
  1.5.1 Europe Drug-Eluting Stents Sales and Growth Rate (2011-2021)
  1.5.2 Europe Drug-Eluting Stents Revenue and Growth Rate (2011-2021)

2 EUROPE DRUG-ELUTING STENTS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Drug-Eluting Stents Market Competition by Manufacturers
  2.1.1 Europe Drug-Eluting Stents Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Drug-Eluting Stents Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Drug-Eluting Stents (Volume and Value) by Type
  2.2.1 Europe Drug-Eluting Stents Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Drug-Eluting Stents Revenue and Market Share by Type (2011-2016)
2.3 Europe Drug-Eluting Stents (Volume and Value) by Countries
  2.3.1 Europe Drug-Eluting Stents Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Drug-Eluting Stents Revenue and Market Share by Countries (2011-2016)
2.4 Europe Drug-Eluting Stents (Volume) by Application

3 GERMANY DRUG-ELUTING STENTS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Drug-Eluting Stents Sales and Value (2011-2016)
  3.1.1 Germany Drug-Eluting Stents Sales and Growth Rate (2011-2016)
  3.1.2 Germany Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Drug-Eluting Stents Sales Price Trend (2011-2016)
3.2 Germany Drug-Eluting Stents Sales and Market Share by Manufacturers
3.3 Germany Drug-Eluting Stents Sales and Market Share by Type
3.4 Germany Drug-Eluting Stents Sales and Market Share by Application

4 FRANCE DRUG-ELUTING STENTS (VOLUME, VALUE AND SALES PRICE)

4.1 France Drug-Eluting Stents Sales and Value (2011-2016)
  4.1.1 France Drug-Eluting Stents Sales and Growth Rate (2011-2016)
  4.1.2 France Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
  4.1.4 France Drug-Eluting Stents Sales Price Trend (2011-2016)
4.2 France Drug-Eluting Stents Sales and Market Share by Manufacturers
4.3 France Drug-Eluting Stents Sales and Market Share by Type
4.4 France Drug-Eluting Stents Sales and Market Share by Application

5 UK DRUG-ELUTING STENTS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Drug-Eluting Stents Sales and Value (2011-2016)
  5.1.1 UK Drug-Eluting Stents Sales and Growth Rate (2011-2016)
  5.1.2 UK Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
  5.1.5 UK Drug-Eluting Stents Sales Price Trend (2011-2016)
5.2 UK Drug-Eluting Stents Sales and Market Share by Manufacturers
5.3 UK Drug-Eluting Stents Sales and Market Share by Type
5.4 UK Drug-Eluting Stents Sales and Market Share by Application

6 RUSSIA DRUG-ELUTING STENTS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Drug-Eluting Stents Sales and Value (2011-2016)
  6.1.1 Russia Drug-Eluting Stents Sales and Growth Rate (2011-2016)
  6.1.2 Russia Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Drug-Eluting Stents Sales Price Trend (2011-2016)
6.2 Russia Drug-Eluting Stents Sales and Market Share by Manufacturers
6.3 Russia Drug-Eluting Stents Sales and Market Share by Type
6.4 Russia Drug-Eluting Stents Sales and Market Share by Application

7 ITALY DRUG-ELUTING STENTS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Drug-Eluting Stents Sales and Value (2011-2016)
  7.1.1 Italy Drug-Eluting Stents Sales and Growth Rate (2011-2016)
  7.1.2 Italy Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Drug-Eluting Stents Sales Price Trend (2011-2016)
7.2 Italy Drug-Eluting Stents Sales and Market Share by Manufacturers
7.3 Italy Drug-Eluting Stents Sales and Market Share by Type
7.4 Italy Drug-Eluting Stents Sales and Market Share by Application

8 SPAIN DRUG-ELUTING STENTS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Drug-Eluting Stents Sales and Value (2011-2016)
  8.1.1 Spain Drug-Eluting Stents Sales and Growth Rate (2011-2016)
  8.1.2 Spain Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Drug-Eluting Stents Sales Price Trend (2011-2016)
8.2 Spain Drug-Eluting Stents Sales and Market Share by Manufacturers
8.3 Spain Drug-Eluting Stents Sales and Market Share by Type
8.4 Spain Drug-Eluting Stents Sales and Market Share by Application

9 BENELUX DRUG-ELUTING STENTS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Drug-Eluting Stents Sales and Value (2011-2016)
  9.1.1 Benelux Drug-Eluting Stents Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Drug-Eluting Stents Sales Price Trend (2011-2016)
9.2 Benelux Drug-Eluting Stents Sales and Market Share by Manufacturers
9.3 Benelux Drug-Eluting Stents Sales and Market Share by Type
9.4 Benelux Drug-Eluting Stents Sales and Market Share by Application

10 EUROPE DRUG-ELUTING STENTS MANUFACTURERS ANALYSIS

10.1 Abbott Vascular (USA)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Drug-Eluting Stents Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Abbott Vascular (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Boston Scientific, Inc. (USA)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Drug-Eluting Stents Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Boston Scientific, Inc. (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Biosensors International Pte Ltd. (Singapore)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Drug-Eluting Stents Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Biosensors International Pte Ltd. (Singapore) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Medtronic, Inc.(USA)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Drug-Eluting Stents Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Medtronic, Inc.(USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 MIV Therapeutics, Inc. (Canada)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Drug-Eluting Stents Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 MIV Therapeutics, Inc. (Canada) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview

11 DRUG-ELUTING STENTS MANUFACTURING COST ANALYSIS

11.1 Drug-Eluting Stents Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Drug-Eluting Stents

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Drug-Eluting Stents Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Drug-Eluting Stents Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE DRUG-ELUTING STENTS MARKET FORECAST (2016-2021)

14.1 Germany Drug-Eluting Stents Sales Forecast (2016-2021)
14.2 France Drug-Eluting Stents Sales Forecast (2016-2021)
14.3 UK Drug-Eluting Stents Sales Forecast (2016-2021)
14.4 Russia Drug-Eluting Stents Sales Forecast (2016-2021)
14.5 Italy Drug-Eluting Stents Sales Forecast (2016-2021)
14.6 Spain Drug-Eluting Stents Sales Forecast (2016-2021)
14.7 Benelux Drug-Eluting Stents Sales Forecast (2016-2021)
14.8 Europe Drug-Eluting Stents Sales Forecast by Type (2016-2021)
14.9 Europe Drug-Eluting Stents Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drug-Eluting Stents
Table Classification of Drug-Eluting Stents
Figure Europe Sales Market Share of Drug-Eluting Stents by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Drug-Eluting Stents
Figure Europe Sales Market Share of Drug-Eluting Stents by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Figure France Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Figure UK Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Figure Russia Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Figure Italy Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Figure Spain Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Figure Benelux Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Figure Europe Drug-Eluting Stents Sales and Growth Rate (2011-2021)
Figure Europe Drug-Eluting Stents Revenue and Growth Rate (2011-2021)
Table Europe Drug-Eluting Stents Sales of Key Manufacturers (2015 and 2016)
Table Europe Drug-Eluting Stents Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drug-Eluting Stents Sales Share by Manufacturers
Figure 2016 Drug-Eluting Stents Sales Share by Manufacturers
Table Europe Drug-Eluting Stents Revenue by Manufacturers (2015 and 2016)
Table Europe Drug-Eluting Stents Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Drug-Eluting Stents Revenue Share by Manufacturers
Table 2016 Europe Drug-Eluting Stents Revenue Share by Manufacturers
Table Europe Drug-Eluting Stents Sales and Market Share by Type (2011-2016)
Table Europe Drug-Eluting Stents Sales Share by Type (2011-2016)
Figure Sales Market Share of Drug-Eluting Stents by Type (2011-2016)
Figure Europe Drug-Eluting Stents Sales Growth Rate by Type (2011-2016)
Table Europe Drug-Eluting Stents Revenue and Market Share by Type (2011-2016)
Table Europe Drug-Eluting Stents Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drug-Eluting Stents by Type (2011-2016)
Figure Europe Drug-Eluting Stents Revenue Growth Rate by Type (2011-2016)
Table Europe Drug-Eluting Stents Sales and Market Share by Countries (2011-2016)
Table Europe Drug-Eluting Stents Sales Share by Countries (2011-2016)
Figure Sales Market Share of Drug-Eluting Stents by Countries (2011-2016)
Table Europe Drug-Eluting Stents Revenue and Market Share by Countries (2011-2016)
Table Europe Drug-Eluting Stents Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Drug-Eluting Stents by Countries (2011-2016)
Table Europe Drug-Eluting Stents Sales and Market Share by Application (2011-2016)
Table Europe Drug-Eluting Stents Sales Share by Application (2011-2016)
Figure Sales Market Share of Drug-Eluting Stents by Application (2011-2016)
Figure Germany Drug-Eluting Stents Sales and Growth Rate (2011-2016)
Figure Germany Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
Figure Germany Drug-Eluting Stents Sales Price Trend (2011-2016)
Table Germany Drug-Eluting Stents Sales by Manufacturers (2015 and 2016)
Table Germany Drug-Eluting Stents Market Share by Manufacturers (2015 and 2016)
Table Germany Drug-Eluting Stents Sales by Type (2015 and 2016)
Table Germany Drug-Eluting Stents Market Share by Type (2015 and 2016)
Table Germany Drug-Eluting Stents Sales by Application (2015 and 2016)
Table Germany Drug-Eluting Stents Market Share by Application (2015 and 2016)
Figure France Drug-Eluting Stents Sales and Growth Rate (2011-2016)
Figure France Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
Figure France Drug-Eluting Stents Sales Price Trend (2011-2016)
Table France Drug-Eluting Stents Sales by Manufacturers (2015 and 2016)
Table France Drug-Eluting Stents Market Share by Manufacturers (2015 and 2016)
Table France Drug-Eluting Stents Sales by Type (2015 and 2016)
Table France Drug-Eluting Stents Market Share by Type (2015 and 2016)
Table France Drug-Eluting Stents Sales by Application (2015 and 2016)
Table France Drug-Eluting Stents Market Share by Application (2015 and 2016)
Figure UK Drug-Eluting Stents Sales and Growth Rate (2011-2016)
Figure UK Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
Figure UK Drug-Eluting Stents Sales Price Trend (2011-2016)
Table UK Drug-Eluting Stents Sales by Manufacturers (2015 and 2016)
Table UK Drug-Eluting Stents Market Share by Manufacturers (2015 and 2016)
Table UK Drug-Eluting Stents Sales by Type (2015 and 2016)
Table UK Drug-Eluting Stents Market Share by Type (2015 and 2016)
Table UK Drug-Eluting Stents Sales by Application (2015 and 2016)
Table UK Drug-Eluting Stents Market Share by Application (2015 and 2016)
Figure Russia Drug-Eluting Stents Sales and Growth Rate (2011-2016)
Figure Russia Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
Figure Russia Drug-Eluting Stents Sales Price Trend (2011-2016)
Table Russia Drug-Eluting Stents Sales by Manufacturers (2015 and 2016)
Table Russia Drug-Eluting Stents Market Share by Manufacturers (2015 and 2016)
Table Russia Drug-Eluting Stents Sales by Type (2015 and 2016)
Table Russia Drug-Eluting Stents Market Share by Type (2015 and 2016)
Table Russia Drug-Eluting Stents Sales by Application (2015 and 2016)
Table Russia Drug-Eluting Stents Market Share by Application (2015 and 2016)
Figure Italy Drug-Eluting Stents Sales and Growth Rate (2011-2016)
Figure Italy Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
Figure Italy Drug-Eluting Stents Sales Price Trend (2011-2016)
Table Italy Drug-Eluting Stents Sales by Manufacturers (2015 and 2016)
Table Italy Drug-Eluting Stents Market Share by Manufacturers (2015 and 2016)
Table Italy Drug-Eluting Stents Sales by Type (2015 and 2016)
Table Italy Drug-Eluting Stents Market Share by Type (2015 and 2016)
Table Italy Drug-Eluting Stents Sales by Application (2015 and 2016)
Table Italy Drug-Eluting Stents Market Share by Application (2015 and 2016)
Figure Spain Drug-Eluting Stents Sales and Growth Rate (2011-2016)
Figure Spain Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
Figure Spain Drug-Eluting Stents Sales Price Trend (2011-2016)
Table Spain Drug-Eluting Stents Sales by Manufacturers (2015 and 2016)
Table Spain Drug-Eluting Stents Market Share by Manufacturers (2015 and 2016)
Table Spain Drug-Eluting Stents Sales by Type (2015 and 2016)
Table Spain Drug-Eluting Stents Market Share by Type (2015 and 2016)
Table Spain Drug-Eluting Stents Sales by Application (2015 and 2016)
Table Spain Drug-Eluting Stents Market Share by Application (2015 and 2016)
Figure Benelux Drug-Eluting Stents Sales and Growth Rate (2011-2016)
Figure Benelux Drug-Eluting Stents Revenue and Growth Rate (2011-2016)
Figure Benelux Drug-Eluting Stents Sales Price Trend (2011-2016)
Table Benelux Drug-Eluting Stents Sales by Manufacturers (2015 and 2016)
Table Benelux Drug-Eluting Stents Market Share by Manufacturers (2015 and 2016)
Table Benelux Drug-Eluting Stents Sales by Type (2015 and 2016)
Table Benelux Drug-Eluting Stents Market Share by Type (2015 and 2016)
Table Benelux Drug-Eluting Stents Sales by Application (2015 and 2016)
Table Benelux Drug-Eluting Stents Market Share by Application (2015 and 2016)
Table Drug-Eluting Stents Basic Information List
Table Abbott Vascular (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Vascular (USA) Drug-Eluting Stents Sales Market Share (2011-2016)
Table Boston Scientific, Inc. (USA) Basic Information List
Table Boston Scientific, Inc. (USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boston Scientific, Inc. (USA) Drug-Eluting Stents Sales Market Share (2011-2016)
Table Biosensors International Pte Ltd. (Singapore) Basic Information List
Table Biosensors International Pte Ltd. (Singapore) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biosensors International Pte Ltd. (Singapore) Drug-Eluting Stents Sales Market Share (2011-2016)
Table Medtronic, Inc.(USA) Basic Information List
Table Medtronic, Inc.(USA) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic, Inc.(USA) Drug-Eluting Stents Sales Market Share (2011-2016)
Table MIV Therapeutics, Inc. (Canada) Basic Information List
Table MIV Therapeutics, Inc. (Canada) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2011-2016)
Table MIV Therapeutics, Inc. (Canada) Drug-Eluting Stents Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug-Eluting Stents
Figure Manufacturing Process Analysis of Drug-Eluting Stents
Figure Drug-Eluting Stents Industrial Chain Analysis
Table Raw Materials Sources of Drug-Eluting Stents Major Manufacturers in 2015
Table Major Buyers of Drug-Eluting Stents
Table Distributors/Traders List
Figure Germany Drug-Eluting Stents Sales and Growth Rate Forecast (2016-2021)
Figure Germany Drug-Eluting Stents Revenue and Growth Rate Forecast (2016-2021)
Figure France Drug-Eluting Stents Sales and Growth Rate Forecast (2016-2021)
Figure France Drug-Eluting Stents Revenue and Growth Rate Forecast (2016-2021)
Figure UK Drug-Eluting Stents Sales and Growth Rate Forecast (2016-2021)
Figure UK Drug-Eluting Stents Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Drug-Eluting Stents Sales and Growth Rate Forecast (2016-2021)
Figure Russia Drug-Eluting Stents Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Drug-Eluting Stents Sales and Growth Rate Forecast (2016-2021)
Figure Italy Drug-Eluting Stents Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Drug-Eluting Stents Sales and Growth Rate Forecast (2016-2021)
Figure Spain Drug-Eluting Stents Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Drug-Eluting Stents Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Drug-Eluting Stents Revenue and Growth Rate Forecast (2016-2021)
Table Europe Drug-Eluting Stents Sales Forecast by Type (2016-2021)
Table Europe Drug-Eluting Stents Sales Forecast by Application (2016-2021)